Cargando…
Real-World Experience of Safety of Mycophenolate Mofetil in 119 Japanese Patients with Systemic Lupus Erythematosus: A Retrospective Single-Center Study
OBJECTIVES: Mycophenolate mofetil (MMF) is the standard treatment for lupus nephritis. In Japan, it was approved for lupus nephritis in 2015. We investigated its real-world safety and effectiveness in Japanese patients with systemic lupus erythematosus (SLE). METHODS: We analyzed the continuation ra...
Autores principales: | Abe, Yoshiyuki, Tada, Kurisu, Yamaji, Ken, Tamura, Naoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850850/ https://www.ncbi.nlm.nih.gov/pubmed/33564682 http://dx.doi.org/10.1155/2021/8630596 |
Ejemplares similares
-
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
por: Marques, R, et al.
Publicado: (2010) -
Mycophenolate Mofetil (MMF) for the treatment of juvenile onset systemic lupus erythematosus
por: Falcini, FF, et al.
Publicado: (2008) -
Mycophenolate Mofetil for Systemic Lupus Erythematosus: Our 20-Year Experience
por: Trevisonno, Michael, et al.
Publicado: (2023) -
Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008) -
Bullous Systemic Lupus Erythematosus Successfully Treated With Intravenous Immunoglobulin and Mycophenolate Mofetil
por: Chow, Kevin W, et al.
Publicado: (2023)